Mixed Glioma — Trials

Mixed Glioma — Trials · CancerIndex

Clinical trials

Registered studies

101 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–19 of 19 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02530320	Safety and Efficacy of PD0332991 (Palbociclib), a Cyclin-dependent Kinase 4 and 6 Inhibitor, in Patients With Oligodendroglioma or Recurrent Oligoastrocytoma Anaplastic With the Activity of the Protein RB Preserved	completed	Phase 2	34	Grupo Español de Investigación en NeurooncologíaOTHER	1	Nov 22, 2024	clinicaltrials
NCT00303849	Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain Tumors	completed	Phase 1 / Phase 2	33	OHSU Knight Cancer InstituteOTHER	1	Mar 17, 2022	clinicaltrials
NCT01189266	Vorinostat and Radiation Therapy Followed by Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma	completed	Phase 1 / Phase 2	79	National Cancer Institute (NCI)NIH	3	Oct 28, 2021

Data updated 22 days agoSource updated Nov 22, 2024source: clinicaltrials